30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Ovid Therapeutics Inc (OVID)

Track

The most recent insider trading activity occurred on February 23, 2026, with two transactions: a planned sale by CBFO Rona Jeffrey A and a sale by President and CEO Alexander Margaret A. Prior to this, on February 26, 2025, both Alexander Margaret A and Rona Jeffrey A made sales. Earlier, on January 27, 2025, Alexander Margaret A executed a buy transaction.
Stock chart
Ticker: OVID Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Rona Jeffrey A
CBFO
1 sale — total 12,384 USD
Planned sale 23 Feb 2026
Value US$4,361,497.80 | Price 362.62 | Shares 15,708
Sale 23 Feb 2026
Value US$3,561,515.67 | Price 436.01 | Shares 69,873
Sale 26 Feb 2025
Value US$2,956.24 | Price 0.56 | Shares 5,279
Sale 26 Feb 2025
Value US$2,185.12 | Price 0.56 | Shares 3,902
Buy 27 Jan 2025
Value US$4,971.30 | Price 0.73 | Shares 6,810
Buy 18 Mar 2024
Value US$50,364.48 | Price 2.76 | Shares 18,248
Planned sale 12 Sep 2022
Value US$37,289.60 | Price 2.15 | Shares 17,344
Buy 28 Aug 2020
Value US$49,569.92 | Price 5.84 | Shares 8,488
Buy 8 Oct 2019
Value US$5,000,000.00 | Price 2.50 | Shares 2,000,000
Buy 8 Oct 2019
Value US$150,000.00 | Price 2.50 | Shares 60,000
Buy 26 Feb 2019
Value US$20,210.00 | Price 2.02 | Shares 10,000
Buy 22 Feb 2019
Value US$150,000.00 | Price 2.00 | Shares 75,000
Buy 14 Aug 2018
Value US$62,300.00 | Price 6.23 | Shares 10,000
Buy 14 Aug 2018
Value US$32,441.50 | Price 6.49 | Shares 5,000
Buy 25 Aug 2017
Value US$109,638.10 | Price 7.15 | Shares 15,334
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-02 2026-02-23 PlS Planned sale
3.3
Rona Jeffrey A

CBFO

Officer
15,708 -26.8%
362.62
US$4,361,498 		15,708 -26.8% 362.62 US$4,361,498
2026-03-02 2026-02-23 S Sale
1.8
ALEXANDER MARGARET A.

President and CEO

Executive Director
69,873 -44.4%
436.01
US$3,561,516 		69,873 -44.4% 436.01 US$3,561,516
2025-02-28 2025-02-26 S Sale
1.8
ALEXANDER MARGARET A.

President and COO

Officer
92,612 -26.5%
127.18
US$208,433 		92,612 -26.5% 127.18 US$208,433
2025-02-28 2025-02-26 S Sale
3.3
Rona Jeffrey A

CBFO

Officer
3,902 -5.4%
0.56
US$2,185 		3,902 -5.4% 0.56 US$2,185
2025-01-29 2025-01-27 B Purchase
1.8
ALEXANDER MARGARET A.

President and COO

Officer
6,810 +24.2%
0.73
US$4,971 		6,810 +24.2% 0.73 US$4,971
2024-03-20 2024-03-18 B Purchase
3.0
LEVIN JEREMY M

CEO

Executive Director
18,248 +0.5%
2.76
US$50,364 		18,248 +0.5% 2.76 US$50,364
2022-09-14 2022-09-12 PlS Planned sale
2.2
Tardio Jason

Chief Operating Officer

Officer
17,344 -100.0%
2.15
US$37,290 		17,344 -100.0% 2.15 US$37,290
2020-09-01 2020-08-28 B Purchase
3.0
LEVIN JEREMY M

CEO

Executive Director Large shareholder
8,488 +0.1%
5.84
US$49,570 		8,488 +0.1% 5.84 US$49,570
2019-11-22 2019-10-08 B Purchase TAKEDA PHARMACEUTICAL CO LTD Large shareholder
2,000,000 +53.3%
2.50
US$5,000,000 		2,000,000 +53.3% 2.50 US$5,000,000
2019-10-10 2019-10-08 B Purchase
3.0
LEVIN JEREMY M

CEO

Executive Director Large shareholder
60,000 +1.3%
2.50
US$150,000 		60,000 +1.3% 2.50 US$150,000
2019-02-28 2019-02-26 B Purchase
0.7
Bernstein Karen
Non-Executive Director
10,000 +100.0%
2.02
US$20,210 		10,000 +100.0% 2.02 US$20,210
2019-02-26 2019-02-22 B Purchase
3.0
LEVIN JEREMY M

CEO

Executive Director Large shareholder
75,000 +1.6%
2.00
US$150,000 		75,000 +1.6% 2.00 US$150,000
2018-08-16 2018-08-14 B Purchase Bernstein Karen Non-Executive Director
10,000 +inf%
6.23
US$62,300 		10,000 +inf% 6.23 US$62,300
2018-08-16 2018-08-14 B Purchase WILLIAMS DOUGLAS E Non-Executive Director
5,000 +inf%
6.49
US$32,442 		5,000 +inf% 6.49 US$32,442
2017-08-28 2017-08-25 B Purchase LEVIN JEREMY M

CEO

Executive Director Large shareholder
15,334 +0.3%
7.15
US$109,638 		15,334 +0.3% 7.15 US$109,638
Explore more

More insider trading research around Ovid Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America